Newsby HottubFor agents

Mint

FDA flags potential vision loss risk linked to GLP-1 drugs: What users of weight-loss medications should know

FDA analysis of 126 clinical trials involving 134,253 participants found higher NAION incidence among GLP-1 drug users than those taking placebos or other diabetes medications.

Add to CRM by Hottub

Everyone in this article who could become a relationship. Add opens CRM by Hottub's form, filled in; nothing is saved until you press Add there.